Your browser doesn't support javascript.
loading
Understanding and identifying immortal-time bias in surgical health services research: An example using surgical resection of stage IV breast cancer.
Jackson, Bradford E; Greenup, Rachel A; Strassle, Paula D; Deal, Allison M; Baggett, Chris D; Lund, Jennifer L; Reeder-Hayes, Katie E.
Afiliación
  • Jackson BE; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC, USA. Electronic address: beaj@email.unc.edu.
  • Greenup RA; Department of Surgery, Duke University, Durham, NC, USA; Duke Cancer Institute, Duke University, Durham, NC, USA.
  • Strassle PD; Department of Surgery, University of North Carolina, Chapel Hill, NC, USA; Department of Epidemiology, Gillings School of Global Public Health, USA.
  • Deal AM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC, USA.
  • Baggett CD; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC, USA; Department of Epidemiology, Gillings School of Global Public Health, USA.
  • Lund JL; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC, USA; Department of Epidemiology, Gillings School of Global Public Health, USA.
  • Reeder-Hayes KE; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC, USA; Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC, USA.
Surg Oncol ; 37: 101539, 2021 Jun.
Article en En | MEDLINE | ID: mdl-33706057
ABSTRACT
Surgical health services researchers are increasingly utilizing observational data to assess associations between treatments and outcomes, especially since some procedures are unable to be evaluated through randomized controlled trials. However, the results of many of these studies may be affected by the presence of immortal-time bias, which exists when treatment does not occur on Day 0 of the study. This bias can result in researchers overestimating a treatment benefit, or even observe a treatment benefit when none exists. In this paper, we describe what immortal-time bias is, the challenges it presents, and how to recognize and address it using the real-world example of surgical resection of the primary tumor for stage IV breast cancer throughout. In our example, we guide researchers and illustrate how the early studies, which did not account for immortal-time bias, suggested a protective benefit of surgery, and how these results were supplanted by more recent studies through identifying and addressing immortal-time bias in their design and analyses.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Sesgo / Investigación sobre Servicios de Salud / Mastectomía Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Sesgo / Investigación sobre Servicios de Salud / Mastectomía Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article